Article
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.
Cancer medicine - 1 Mar 2022
Layman Rachel M, Lin Heather, Gutierrez Barrera Angelica M, Karuturi Meghan S, Yam Clinton, Arun Banu K
Abstract excerpt
BACKGROUND: BRCA-associated breast cancers tend to have distinctive features compared to sporadic breast cancers; further characterization can aid in optimizing treatment. METHODS: The study evaluated a patient cohort with early-stage estrogen receptor positive, HER2 negative invasive breast cancer who had Oncotype DX Breast Recurrence Score® analysis and genetic testing for hereditary breast and ovarian cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.